legaldesire.comAUG 262 min read

Latham Advises on Financing for Neuberger Berman-Backed Marquee Brands’ Acquisition of Roots

Roots Corporation (TSX: ROOT) will be acquired by Marquee Brands, backed by Neuberger Berman, with JM&A Design and Development Inc. as the operating partner. The deal aims to expand Roots' global presence while maintaining its Canadian operations. Latham & Watkins advised on the financing.

Original reporting

legaldesire.com

Published Aug 26, 2026, 3:10 AM UTC

Analysis

alphai AI DeskAI-generated

Added to alphai Aug 26, 2026, 12:10 PM UTC. Informational, not investment advice.

How this was made

alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.

About alphai AI Desk Scoring methodology Report an issue

Latham Advises on Financing for Neuberger Berman-Backed Marquee Brands’ Acquisition of Roots — source image — Source · legaldesire.com

Decision brief

The 30-second read

Med

Why it matters

The acquisition could expand Marquee's brand portfolio and provide growth avenues for Roots.

Market read

A cross-border brand acquisition with potential modest market impact.

What to watch

Financing terms and integration risks could affect execution.

Relevance 6/10Novelty 7/10Timing: announcement on 2026-08-26

Background

Marquee Brands, backed by Neuberger Berman, is acquiring Canadian brand Roots.

Market effects

Sector

Potential consolidation in the apparel and lifestyle brand sector.

Regional

May affect Canadian consumer goods market sentiment.

Global

Limited global impact beyond brand portfolio considerations.

Counterpoint

What could challenge this read

Deal size undisclosed; market may overestimate impact.

Key entities

Company
Marquee Brands
Global brand management firm acquiring Roots.
Company
Roots Corporation
Canadian heritage outdoor and lifestyle brand being acquired.

Read at source ← All news

AUG 28

$AMDHighAI 9/10

Latham & Watkins Advises AMD in River AI’s US$1.1 Billion Funding

River AI, founded by Igor Babuschkin, raised $1.1B in funding led by General Catalyst and AMP PBC, with strategic investments from AMD and NVIDIA. The funds will support its AI development and tools for developers. Latham & Watkins advised AMD in the transaction.

legaldesire.com1 min

AUG 27

$STEPMedAI 8/10

Latham & Watkins Advises StepStone Group on US$1.7 Billion Secondaries Infrastructure Fundraise

StepStone Group Inc. (STEP) closed a $1.7 billion fundraise for its StepStone Secondaries Infrastructure Fund. Latham & Watkins LLP advised on the fund formation, with contributions from multiple partners and associates across various legal and regulatory matters.

lw.com1 min

AUG 26

$BCCQUHighAI 9/10

Latham Advises Ursa Major Technologies on US$2.3 Billion Merger With Bleichroeder Acquisition Corp.

Ursa Major Technologies (private) will merge with SPAC Bleichroeder Acquisition Corp. (Nasdaq: BCCQU), forming Inflection Point Mach X Bleichroeder (Nasdaq: IPXX). The deal is valued at US$2.3 billion, with US$350 million in PIPE commitments. Latham & Watkins advised Ursa Major on the transaction.

legaldesire.com2 min

AUG 22

Med

Latham Group Refinances Capital Structure with New Credit Facilities

Latham Group (SWIM) refinanced its capital structure with new credit facilities totaling $375 million. The facilities include a $75 million revolving credit line and a $300 million term loan, both secured by company assets. Proceeds were used to repay existing debt. The facilities mature in 2031 and 2033, respectively, and include leverage-based interest margins and covenants.

theglobeandmail.com1 min

AUG 21

$HOWLHighAI 8/10

Latham & Watkins Advises on Oversubscribed US$150 Million Private Placement in Connection With Werewolf Therapeutics and Ambros Therapeutics’ Reverse Merger Transaction

Werewolf Therapeutics (HOWL) and Ambros Therapeutics agreed to merge in an all-stock deal. The combined company will focus on Ambros' neridronate program for CRPS-1 and trade as AMBX. They secured $150M in private placement from healthcare investors. Latham & Watkins advised on the transaction.

lw.com2 min